Results 41 to 50 of about 89 (85)

NOTTO guidelines for vaccine induced thrombotic thrombocytopenia in organ donation and transplantation

Indian Journal of Nephrology, 2023
From the context of organ donation, COVID-19 vaccine-induced thrombotic thrombocytopenia (VITT) is important as there is an ethical dilemma in utilizing versus discarding organs from potential donors succumbing to VITT. This consensus statement is an attempt by the National Organ and Tissue Transplant Organization (NOTTO) apex technical committees ...
Kute, Vivek, Asthana, Sonal, Gupta, Subhash, Agarwal, Sanjay K., Swarnalatha, G, Sahay, Manisha, Pal, Sujoy, Sudhindran, S., Sharma, Ashish, Seth, Sandeep, Gokhale, Alla Gopala Krishna, Hote, Milind D., Chaudhury, Arpita R., Soin, Arvinder S., Rela, Mohamed, Malhotra, Rajesh, Bansal, Virinder K., Rana, Devinder S., Ramesh, Vasanthi   +18 more
openaire   +2 more sources

Respiratory Syncytial Virus (RSV): A Comprehensive Overview From Basic Biology to Clinical Prevention and Control

Medicinal Research Reviews, Volume 46, Issue 3, Page 672-712, May 2026.
ABSTRACT Respiratory syncytial virus (RSV) is a common virus that causes respiratory infections, posing a serious threat, particularly to infants, the elderly, and individuals with compromised immune systems. As the leading cause of lower respiratory tract infections (LRTIs) in infants, RSV is responsible for millions of cases worldwide each year.
Jie Shi, Xiya Huang, Chunjun Ye, Yishan Lu, Yanyan Liu, Yuquan Wei, Xiawei Wei   +6 more
wiley   +1 more source

Monoclonal gammopathy of thrombotic significance in a nutshell

British Journal of Haematology, Volume 208, Issue 5, Page 1551-1554, May 2026.
Summary This nutshell review discusses the pathophysiology, diagnostic features, treatment strategies and avenues for future research in a recently identified thrombotic entity, monoclonal gammopathy of thrombotic significance (MGTS). MGTS is an anti‐platelet factor 4 (PF4) antibody‐mediated disorder distinct from heparin‐induced thrombocytopenia (HIT)
Adam J. Kanack, Emily E. Mauch, David L. Murray, Anand Padmanabhan   +3 more
wiley   +1 more source

Genetic predisposition to vaccine‐induced immune thrombotic thrombocytopenia

British Journal of Haematology
Vaccine‐induced immune thrombotic thrombocytopenia (VITT) is a rare prothrombotic disorder with a unique clonality‐restricted immunological profile. The study by Petito and Bury et al. provides insight into the role of HLA polymorphisms and an inherent predisposition to VITT.Commentary on: Petito et al.
Donald M. Arnold, Guillaume Paré, Ishac Nazy   +2 more
openaire   +2 more sources

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

British Journal of Pharmacology, Volume 183, Issue 9, Page 1779-1813, May 2026.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos, Stavros Topouzis, Steve P. H. Alexander, Miriam M. Cortese‐Krott, Zsuzsanna Helyes, Kirill Martemyanov, Claudio Mauro, Nithyanandan Nagercoil, Reynold A. Panettieri Jr, Hemal H. Patel, Rainer Schulz, Barbara Stefanska, Gary J. Stephens, Nathalie Vergnolle, Xin Wang, Stephen Ward, Péter Ferdinandy   +16 more
wiley   +1 more source

Common Gynecologic Issues in Patients Post‐Kidney Transplantation

Clinical Transplantation, Volume 40, Issue 5, May 2026.
ABSTRACT Advances in kidney transplantation have transformed survival and quality of life for women with end‐stage renal disease, necessitating a focus on long‐term health care for this population. Female kidney transplant recipients (KTR) experience a unique spectrum of gynecologic issues shaped by persistent hormonal dysregulation, lifelong ...
Mary Elaine Graham, Janelle Moulder, Eva Reina, Oona O'Neill, Emily McCracken   +4 more
wiley   +1 more source

Laboratory approach for vaccine‐induced thrombotic thrombocytopenia diagnosis in the Netherlands

Vox Sanguinis
AbstractBackground and ObjectivesVaccine‐induced thrombotic thrombocytopenia (VITT) is a rare adverse effect characterized by thrombocytopenia and thrombosis occurring after COVID‐19 vaccination. VITT pathophysiology is not fully unravelled but shows similarities to heparin‐induced thrombocytopenia (HIT).
Romy T. Meier, Leendert Porcelijn, Suzanne Hofstede‐van Egmond, Yvonne M. C. Henskens, Jonathan M. Coutinho, Marieke J. H. A. Kruip, An K. Stroobants, Jaap J. Zwaginga, Johanna G. van der Bom, C. Ellen van der Schoot, Masja de Haas, Rick Kapur   +11 more
openaire   +4 more sources

Whole Exome Sequencing in Vaccine‐Induced Thrombotic Thrombocytopenia (VITT)

BioMed Research International
Background: In February 2021, a few cases of unusual, severe thrombotic events associated with thrombocytopenia reported after vaccination with ChAdOx1 nCoV‐19 (Vaxzevria) or with Johnson & Johnson’s Janssen vaccine raise concern about safety.
Betti Giusti, Elena Sticchi, Tommaso Capezzuoli, Rebecca Orsi, Lapo Squillantini, Marco Giannini, Samuele Suraci, Angela Antonietta Rogolino, Francesca Cesari, Martina Berteotti, Anna Maria Gori, Elena Lotti, Rossella Marcucci   +12 more
openaire   +2 more sources

Vaccine induced thrombotic thrombocytopenia

Asian Pacific Journal of Tropical Medicine, 2021
Cokorda Agung Wahyu Purnamasidhi, I Komang Hotra Adiputra, Giovanca Verentzia Purnama, Richard Christian Suteja, I Gede Purna Weisnawa   +4 more
openaire   +2 more sources

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source